<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D"><gtr:id>DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D</gtr:id><gtr:name>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB"><gtr:id>7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB</gtr:id><gtr:name>University of Geneva</gtr:name><gtr:address><gtr:line1>University of Geneva</gtr:line1><gtr:line2>30 Quai Ernest-Ansemet</gtr:line2><gtr:postCode>CH-1211</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5589D756-E334-47E6-9A29-7932ED64B2A1"><gtr:id>5589D756-E334-47E6-9A29-7932ED64B2A1</gtr:id><gtr:name>Valencia University</gtr:name><gtr:address><gtr:line1>Valencia University</gtr:line1><gtr:line2>Avda. Bianca Ibanez 13</gtr:line2><gtr:line4>Valencia</gtr:line4><gtr:postCode>46010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Asthma Allergy and Lung Biology</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D"><gtr:id>DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D</gtr:id><gtr:name>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB"><gtr:id>7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB</gtr:id><gtr:name>University of Geneva</gtr:name><gtr:address><gtr:line1>University of Geneva</gtr:line1><gtr:line2>30 Quai Ernest-Ansemet</gtr:line2><gtr:postCode>CH-1211</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5589D756-E334-47E6-9A29-7932ED64B2A1"><gtr:id>5589D756-E334-47E6-9A29-7932ED64B2A1</gtr:id><gtr:name>Valencia University</gtr:name><gtr:address><gtr:line1>Valencia University</gtr:line1><gtr:line2>Avda. Bianca Ibanez 13</gtr:line2><gtr:line4>Valencia</gtr:line4><gtr:postCode>46010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D9467A28-487A-4FE0-8749-22FB36BBC465"><gtr:id>D9467A28-487A-4FE0-8749-22FB36BBC465</gtr:id><gtr:firstName>Alexandra</gtr:firstName><gtr:surname>Santos</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902018"><gtr:id>2354D5C2-10DB-4C12-968F-C4443C30C025</gtr:id><gtr:title>Diagnostic markers of clinical allergy versus sensitisation to peanut</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0902018</gtr:grantReference><gtr:abstractText>Peanut allergy (PA) is particularly problematic since it is increasingly common in infants and
children, may be life-threatening, frequently persists through adulthood and has a significant impact
on children?s quality of life.
The diagnosis of PA is based on a combination of a history of allergic reaction(s) to peanut and
positive allergy tests. However, this is not reliable because many patients have positive allergy tests
and tolerate peanut whilst others have positive allergy tests and are peanut allergic. The only way to
clarify this is by giving the child peanuts in oral food challenges (OFC). However, OFC are expensive,
laborious and potentially dangerous, as they may induce allergic reactions.
Our proposed research project aims to provide fundamental insights into the mechanisms of
allergy and tolerance and also to distinguish between peanut allergic children and those who have
positive allergy tests but tolerate peanut without the need for OFC.
This project will improve allergy diagnosis, allowing for a more accurate distinction of allergic
children among children with positive allergy tests, not only to peanut but also to other allergens. By
understanding why some children with positive allergy tests react and others do not, we may
develop new definitive treatments for PA</gtr:abstractText><gtr:technicalSummary>Background: In the United Kingdom, 2% of primary school children will develop peanut allergy but
10% will develop serum specific IgE to peanut. This poses diagnostic difficulties and dangerous oral
food challenges(OFC) are required. Why is it that some patients have high serum specific IgE levels
to peanut and tolerate it and others have low specific IgE levels and react violently?
Hypotheses:
Two separate hypotheses will be addressed:
1. Peanut specific IgE is functionally different in allergic and tolerant children;
2. The functionality of peanut specific IgE is similar and sensitized but tolerant children have an
inhibitor that blocks IgE function.
Objectives:
1) To understand the immunological differences that underpin sensitization and allergy;
2) To improve the diagnosis of peanut allergy while reducing the need for OFC.
Study design:
Four groups of children will be compared:
- Peanut allergic(PA) ? peanut IgE positive and peanut allergic(n=25);
- Peanut sensitized(PS) ? peanut IgE positive, never reacted to peanut and eat peanut(n=25);
- Peanut allergy resolved(PR) ? peanut IgE positive and have outgrown peanut allergy(n=25);
- Non-allergic(NA) ? peanut IgE negative and eat peanut(n=25).
PA, PS and PR groups will be matched for serum peanut specific IgE levels.
Methodology:
To test the first hypothesis, we will:
- perform basophil mediator release assays(histamine, IL-4 and IL-13), following pre-incubation
with sera and subsequent stimulation with peanut extract;
- purify IgE from sensitised but tolerant children(PS and PR) and assess whether it induces
basophil histamine release;
- analyse peanut specific IgE for specificity and clonality(peanut peptide and epitope recognition
of IgE, using ImmunoCAPTM and microarray immunoassays) and for affinity and avidity(using
surface plasmon resonance).
To test the second hypothesis, we will:
- pool sera from sensitised but tolerant with sera from allergic children and assess whether
basophil mediator release is inhibited;
- purify antibody isotypes other than IgE(e.g IgG4) from sensitised but tolerant children and
assess whether basophil mediator release is inhibited;
- assess basophil intracellular signalling protein activities, excitatory(Syk and p38-MAPK) and
inhibitory(SHIP), on western blotting, in case an inhibition is observed.
Scientific and medical opportunities:
This study will extend our knowledge about the mechanisms that determine clinical reactivity to
peanut in sensitized patients and define superior diagnostic markers for peanut allergy. The results
may be extended to other food and respiratory allergens. By understanding why some IgE react and
other do not, we may target therapeutical strategies to induce tolerance and provide definitive
treatment for allergy.</gtr:technicalSummary><gtr:fund><gtr:end>2013-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>236079</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Geneva</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Basophil activation test in the PRONUTS Study</gtr:description><gtr:id>D57A53C5-B216-4E90-950B-D915BED8FEBE</gtr:id><gtr:impact>No outputs yet as the collaboration is ongoing and data will only be analysed at the end of the study.</gtr:impact><gtr:outcomeId>545e5a992bda49.34637376-2</gtr:outcomeId><gtr:partnerContribution>This is a multicentre study, including the 3 centres indicated above. All centres have been recruiting study participants. At KCL, I collaborate with Dr Helen Brough (PI) and Professor Gideon Lack (CI).</gtr:partnerContribution><gtr:piContribution>I have been performing the basophil activation test in participants in the Pronuts Study at the London site.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Basophil activation test in the PRONUTS Study</gtr:description><gtr:id>4B25892A-74BF-4FE5-8630-0354E3903515</gtr:id><gtr:impact>No outputs yet as the collaboration is ongoing and data will only be analysed at the end of the study.</gtr:impact><gtr:outcomeId>545e5a992bda49.34637376-1</gtr:outcomeId><gtr:partnerContribution>This is a multicentre study, including the 3 centres indicated above. All centres have been recruiting study participants. At KCL, I collaborate with Dr Helen Brough (PI) and Professor Gideon Lack (CI).</gtr:partnerContribution><gtr:piContribution>I have been performing the basophil activation test in participants in the Pronuts Study at the London site.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Valencia</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Basophil activation test in the PRONUTS Study</gtr:description><gtr:id>0338E259-6ADD-458D-A68D-651B4ED7121B</gtr:id><gtr:impact>No outputs yet as the collaboration is ongoing and data will only be analysed at the end of the study.</gtr:impact><gtr:outcomeId>545e5a992bda49.34637376-3</gtr:outcomeId><gtr:partnerContribution>This is a multicentre study, including the 3 centres indicated above. All centres have been recruiting study participants. At KCL, I collaborate with Dr Helen Brough (PI) and Professor Gideon Lack (CI).</gtr:partnerContribution><gtr:piContribution>I have been performing the basophil activation test in participants in the Pronuts Study at the London site.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Auto-anti-IgE project</gtr:description><gtr:id>A4BA37B4-72A1-4741-B5D7-FC3583C36D63</gtr:id><gtr:impact>Publication PMID: 25112697</gtr:impact><gtr:outcomeId>545e5baf409435.32599081-1</gtr:outcomeId><gtr:partnerContribution>Professor Corrigan and his team recruited asthmatic and non-asthmatic subjects to the study and Professor Gould and her team performed experiments to detec the presence of anti-IgE and anti-FceRI and other auto antibodies in the serum of asthmatic and non-asthmatic subjects.</gtr:partnerContribution><gtr:piContribution>I contributed with intellectual input into the project regarding basophil experiments and also performed some experiments as part of this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Basophil activation test in the LEAP and LEAP-On studies</gtr:description><gtr:id>82B733C2-A900-466A-95B8-14D9833CE2CC</gtr:id><gtr:impact>Publications are planned but for the time being we are still blinded for the</gtr:impact><gtr:outcomeId>HZE57EjL2QA-1</gtr:outcomeId><gtr:partnerContribution>The NIAID and the Immune Tolerance Network are funding and monitoring the LEAP and LEAP-On trials.</gtr:partnerContribution><gtr:piContribution>Following successful development of basophil activation test to peanut, we have started to apply this technique to participants in the LEAP and LEAP-On studies.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Asthma UK Event</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E077540E-D1E4-487B-BF1F-B89E26CAC94F</gtr:id><gtr:impact>50 potential donors and members of the public attended this event, where PI and post-doctoral researchers presented about their research and showed them around the laboratories and research facilities. This event was very successful and significantly contributed for the funds needed for the renovation of the 5-year funding period of the centre.</gtr:impact><gtr:outcomeId>56def38b8696e8.32295164</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Global Atlas of Allergy</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>878DDA89-6C5B-4491-97E0-0471160FAA57</gtr:id><gtr:impact>I was an author of one of the chapters in this publication, which has been distributed to attendants of various scientific meetings organised by the European Academy of Allergy and Clinical Immunology.

After this book was published I have been contacted by other researchers interested in my research field and I have been invited to expert panels regarding other initiatives of similar scope.</gtr:impact><gtr:outcomeId>545e53b2a84a76.70484826</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.eaaci.org/globalatlas/GlobalAtlasAllergy.pdf</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Asthma UK event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0C8BBE89-D0EB-46EA-95E2-CEA6559552C4</gtr:id><gtr:impact>About 100 people attended, including Asthma UK's new and existing major supporters, special events committee members and attendees, celebrity contacts and pharmaceutical company contacts.

We showcased the work of the MRC &amp;amp; Asthma UK Centre for the Allergic Mechanisms of Asthma and the new Asthma UK Research strategy (incl. applied centre) and engaged the public, including people with asthma, with Asthma UK's research strategy.</gtr:impact><gtr:outcomeId>gWRCPBu5Xa2</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centenary Open Week Observation Point</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>38F13540-3055-4B1C-83D9-AF07D25CE331</gtr:id><gtr:impact>About 100 members of the public visited the stations we had with information about the research developed at the MRC &amp;amp; Asthma UK Centre in Allergic Mechanisms of Asthma.

The members of the public were quite engaged with the activities we promoted on site, such as peak-flow measurements, models of molecules related to Allergy and a big inflatable lung with examples of diseases that can affect this organ.</gtr:impact><gtr:outcomeId>QDSTnEUNNji</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>450</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel grant to attend the Annual Meeting of the British Society of Allergy and Clinical Immunology 2014</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>British Society of Allergy and Clinical Immunology</gtr:fundingOrg><gtr:id>A2C785A3-220D-47D2-9B1E-BC463BD87CCC</gtr:id><gtr:outcomeId>545e56638141d2.08322719</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>320420</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Immune Tolerance Network/NIAID</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:fundingOrg><gtr:id>E2161F78-E20C-444B-B604-6ED954D3C622</gtr:id><gtr:outcomeId>SxNL1qZjFTc</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>55000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenary Early Career Award</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>BB901614-731D-48F9-A6B9-35452945A1E2</gtr:id><gtr:outcomeId>K5ta4DLUSbf</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EAACI Allergen-specific Immunotherapy Guidelines for Food Allergy</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>9C446389-999C-4EA5-A4B2-94D49737BE01</gtr:id><gtr:outcomeId>58c3aced44f133.74873417</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EAACI Allergen-specific Immunotherapy Guidelines for Prevention of Allergic Disease</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>727C1F4D-8C57-43A3-92B6-6ABA6CF9098C</gtr:id><gtr:outcomeId>58c3ad1f8a6ff6.16464645</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EAACI Anaphylaxis Guidelines</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>7587126A-C5E5-4CD5-8912-AC2E0F226969</gtr:id><gtr:outcomeId>GsamdqHbhLC</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Guidelines for food allergy and weaning</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D9F8E88B-1A56-4501-A9CD-A93986DD01CA</gtr:id><gtr:outcomeId>56def478c7edc2.74767948</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EAACI Food Allergy Guidelines</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>378E7056-0103-45BF-8755-2FE94322D742</gtr:id><gtr:outcomeId>PDRv5zhmZfx</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EAACI Position paper establishing a new framework for the interpretation of IgE sensitisation tests</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>A544A8EA-1A7C-41F0-960D-13B370222E62</gtr:id><gtr:outcomeId>545e54c574eb52.74484284</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EAACI Task Force on Allergen Thresholds</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>9CFD3EFC-7840-46F5-93F1-9C745323E956</gtr:id><gtr:outcomeId>58c3ad628aed58.17106696</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EAACI Position paper about clinical utility of the basophil actuvation test</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>41ACBA75-5BDC-4D38-AE5F-E956856743B6</gtr:id><gtr:outcomeId>545e5475a61a49.77913164</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>The laboratory technique has been developed and validated for peanut allergy. Diagnostic performance and cut-off values have been determined and validated. It is currently being translated to a clinical laboratory with the view of applying it to clinical practice.</gtr:description><gtr:id>B936E25F-2DE6-4B27-9C9E-B84AF614A2D2</gtr:id><gtr:impact>This test will improve the accuracy of the diagnosis of peanut allergy and reduce the number of oral food challenges to peanut.</gtr:impact><gtr:outcomeId>LWcGszUcyWE</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Basophil activation test to peanut</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The whole blood basophil activation test is an in vitro assay where basophils in whole blood are stimulated with allergen and the expression of basophils' surface markers of activation are subsequently measured by flow cytometry. This assay was not previously performed in the host institution, was developed and optimised as part of the present research project and has proven to be very robust and to perform consistently.</gtr:description><gtr:id>9415A3FE-4E01-4F22-BFC7-6C448878DCD7</gtr:id><gtr:impact>The basophil activation test (BAT) will be assessed as a tool for the diagnosis of food allergy and will be used in mechanistic experiments. BAT will be clinically validated and may be applied in the diagnosis of food allergy in clinical practice, reducing the need for oral food challenges and inherent costs and risks. BAT will also be used to unravel immunologic mechanisms of allergy versus tolerance, allowing us to understand why some children with IgE to foods react clinically whilst other children with equivalent levels of IgE do not.</gtr:impact><gtr:outcomeId>D6KGokvfAbU</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Basophil activation test</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The mast cell activation assay is a flow-cytomety based assay where mast cells from a cell line are sensitised with patients' plasma and stimulated with allergens or controls. It is an in vitro surrogate of provocation tests where patients are exposed to the allergens in vivo. 

The inhibition assay is similar, where the mast cells are in the presence of plasma samples that are tested for their ability to suppress mast cell activation. It can be used as a marker for clinical improvement of allergic disease.</gtr:description><gtr:id>F0981DD0-2B83-4F96-913D-54439E1A5880</gtr:id><gtr:impact>It will be used as a biomarker for clinical improvement in clinical trials testing preventive or therapeutic strategies for food allergy.</gtr:impact><gtr:outcomeId>56def5945aa3a8.52029642</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mast cell activation and inhibition assays</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DDA12A58-80D7-4A5B-9537-92C243A0D5A3</gtr:id><gtr:title>Making the Most of In&amp;nbsp;Vitro Tests to Diagnose Food Allergy.</gtr:title><gtr:parentPublicationTitle>The journal of allergy and clinical immunology. In practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2549dbaa3240cc07a8213cd0d29ecc53"><gtr:id>2549dbaa3240cc07a8213cd0d29ecc53</gtr:id><gtr:otherNames>Santos AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c3a97fe12119.76875507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFAD96A8-181C-44E5-A321-775605C1EAA4</gtr:id><gtr:title>Randomized trial of peanut consumption in infants at risk for peanut allergy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80fac0d78b8ac6594fb6e976a5db9ab5"><gtr:id>80fac0d78b8ac6594fb6e976a5db9ab5</gtr:id><gtr:otherNames>Du Toit G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>56deee5626cd61.78088824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>068C2885-D84B-4B4E-A1CF-F9A875787826</gtr:id><gtr:title>The expression of CD123 can decrease with basophil activation: implications for the gating strategy of the basophil activation test.</gtr:title><gtr:parentPublicationTitle>Clinical and translational allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2549dbaa3240cc07a8213cd0d29ecc53"><gtr:id>2549dbaa3240cc07a8213cd0d29ecc53</gtr:id><gtr:otherNames>Santos AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-7022</gtr:issn><gtr:outcomeId>56deed111a0a61.96443476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC7DC03E-C91F-4DF0-96AC-1E2E74396880</gtr:id><gtr:title>Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2549dbaa3240cc07a8213cd0d29ecc53"><gtr:id>2549dbaa3240cc07a8213cd0d29ecc53</gtr:id><gtr:otherNames>Santos AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>545e4e993efbb5.82708119</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA47F047-AC16-4B58-81E2-1A8F4E450131</gtr:id><gtr:title>The history of pediatric allergy in Europe - from a working group to ESPACI and SP-EAACI.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30524126d325d2a6c3f0a35155dc3c7c"><gtr:id>30524126d325d2a6c3f0a35155dc3c7c</gtr:id><gtr:otherNames>Dreborg S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn><gtr:outcomeId>pm_12769_29_23331532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03982066-0125-4C2E-B0D0-B6B88E4ECE31</gtr:id><gtr:title>Basophil activation test: food challenge in a test tube or specialist research tool?</gtr:title><gtr:parentPublicationTitle>Clinical and translational allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2549dbaa3240cc07a8213cd0d29ecc53"><gtr:id>2549dbaa3240cc07a8213cd0d29ecc53</gtr:id><gtr:otherNames>Santos AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-7022</gtr:issn><gtr:outcomeId>56deed113aaec0.10037095</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDADCEF8-B294-4200-B2D4-B5476F322898</gtr:id><gtr:title>Allergen immunotherapy for the prevention of allergy: A systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b2c9e84a2d8cce8f9ac2c9beec0c386"><gtr:id>0b2c9e84a2d8cce8f9ac2c9beec0c386</gtr:id><gtr:otherNames>Kristiansen M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn><gtr:outcomeId>58c3ab7fa2c975.60202803</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B50FF39F-8334-4800-82DC-FB2370F752D6</gtr:id><gtr:title>Is the Prevalence of Food Allergy Not on the Rise After All?</gtr:title><gtr:parentPublicationTitle>The journal of allergy and clinical immunology. In practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2549dbaa3240cc07a8213cd0d29ecc53"><gtr:id>2549dbaa3240cc07a8213cd0d29ecc53</gtr:id><gtr:otherNames>Santos AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c3a83def9b41.22601474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02ACE85E-9FEE-4856-9E5B-64879A4E22E0</gtr:id><gtr:title>Pros and Cons of Clinical Basophil Testing (BAT).</gtr:title><gtr:parentPublicationTitle>Current allergy and asthma reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d08b4fef2f77e873c32763b16edb9adc"><gtr:id>d08b4fef2f77e873c32763b16edb9adc</gtr:id><gtr:otherNames>Hoffmann HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-7322</gtr:issn><gtr:outcomeId>58c3a83dc5c886.22353650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EFFE35D-8F2C-4DBB-9821-68788C117A5F</gtr:id><gtr:title>The epidemiology of anaphylaxis in Europe: a systematic review.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13739d9858b2059412137b8e715e0d8"><gtr:id>b13739d9858b2059412137b8e715e0d8</gtr:id><gtr:otherNames>Panesar SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>pm_12769_29_24117770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56B77386-0142-4DA3-A410-BA676BA5467D</gtr:id><gtr:title>International consensus on allergy immunotherapy.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5331857dc4f84eff8b0e6bf5c0c3197"><gtr:id>c5331857dc4f84eff8b0e6bf5c0c3197</gtr:id><gtr:otherNames>Jutel M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56deec51dc3bc7.59937952</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3ECB742A-DD05-422C-9715-6EE9A5423437</gtr:id><gtr:title>Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review.</gtr:title><gtr:parentPublicationTitle>Clinical and translational allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0961a81b170af963c103f4234fb8ed5"><gtr:id>b0961a81b170af963c103f4234fb8ed5</gtr:id><gtr:otherNames>Dhami S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-7022</gtr:issn><gtr:outcomeId>58c3ab8015c4d2.17295589</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22C0741F-1CB4-4F8D-B342-21E12FDEAC46</gtr:id><gtr:title>A new framework for the interpretation of IgE sensitization tests.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b78a456abb8ee87f5db1c1a7a37a769b"><gtr:id>b78a456abb8ee87f5db1c1a7a37a769b</gtr:id><gtr:otherNames>Roberts G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>58c3a83d8d0cf8.35732335</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9219879-32DB-41A5-82CF-D74393C32FC9</gtr:id><gtr:title>The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d08b4fef2f77e873c32763b16edb9adc"><gtr:id>d08b4fef2f77e873c32763b16edb9adc</gtr:id><gtr:otherNames>Hoffmann HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>56deeb859c2cd2.58550307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9906169-C987-455A-AAF5-D0CBB08BC806</gtr:id><gtr:title>&amp;quot;Auto-anti-IgE&amp;quot;: naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfc1c2bbda309923a8199de5d2aedfb5"><gtr:id>cfc1c2bbda309923a8199de5d2aedfb5</gtr:id><gtr:otherNames>Chan YC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>545e4fce826427.63222676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8AA3458-EF6D-4D72-8C29-E2ACB7237BAC</gtr:id><gtr:title>Food allergy and anaphylaxis in pediatrics: update 2010-2012.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2549dbaa3240cc07a8213cd0d29ecc53"><gtr:id>2549dbaa3240cc07a8213cd0d29ecc53</gtr:id><gtr:otherNames>Santos AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn><gtr:outcomeId>pm_12769_29_23194292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>207BF116-391B-446C-8B2D-2A0D8C2B1A7B</gtr:id><gtr:title>EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad87c8910f2f89cb06aef9d8a5ebb5db"><gtr:id>ad87c8910f2f89cb06aef9d8a5ebb5db</gtr:id><gtr:otherNames>Muraro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>545e50d3f3be54.69381192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB9CBD82-9390-404D-9CEF-FC692EDB41C1</gtr:id><gtr:title>Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad87c8910f2f89cb06aef9d8a5ebb5db"><gtr:id>ad87c8910f2f89cb06aef9d8a5ebb5db</gtr:id><gtr:otherNames>Muraro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>545e50d3cd6357.57069332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F38A708B-E23D-40B9-AA03-EFC3F1C6D931</gtr:id><gtr:title>Peanut protein in household dust is related to household peanut consumption and is biologically active.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7479da87c295dbb6a12108c74ccf59"><gtr:id>6d7479da87c295dbb6a12108c74ccf59</gtr:id><gtr:otherNames>Brough HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>gpzLnNpanqJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E753DCB-63DB-4BB5-971A-840380410164</gtr:id><gtr:title>Effect of Avoidance on Peanut Allergy after Early Peanut Consumption.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80fac0d78b8ac6594fb6e976a5db9ab5"><gtr:id>80fac0d78b8ac6594fb6e976a5db9ab5</gtr:id><gtr:otherNames>Du Toit G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>56deec2e3711a2.85209004</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AD1D46A-E58C-4853-A394-7922137E091B</gtr:id><gtr:title>Research needs in allergy: an EAACI position paper, in collaboration with EFA.</gtr:title><gtr:parentPublicationTitle>Clinical and translational allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9261094ff758ad30fd707b1eebf79713"><gtr:id>9261094ff758ad30fd707b1eebf79713</gtr:id><gtr:otherNames>Papadopoulos NG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2045-7022</gtr:issn><gtr:outcomeId>pm_12769_29_23121771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCD1684C-EA24-47B2-89E8-44313357D78A</gtr:id><gtr:title>Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a494bc19560eabe528a7218a103e73af"><gtr:id>a494bc19560eabe528a7218a103e73af</gtr:id><gtr:otherNames>Nurmatov U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>58c3ab7fdc9cd8.81263310</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F28C8430-3B9E-4063-99D1-3DEFAAAB0DEC</gtr:id><gtr:title>Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2549dbaa3240cc07a8213cd0d29ecc53"><gtr:id>2549dbaa3240cc07a8213cd0d29ecc53</gtr:id><gtr:otherNames>Santos AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>545e4fce5c35e3.40906315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF267B8A-C4E2-4C57-9738-96B6775BA463</gtr:id><gtr:title>The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9201ed11ed9f6711c028a4682cdedb53"><gtr:id>9201ed11ed9f6711c028a4682cdedb53</gtr:id><gtr:otherNames>Skevaki CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn><gtr:outcomeId>pm_12769_29_22122787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E287497-3C14-4EB6-9D0C-1DE2B7049076</gtr:id><gtr:title>Is the use of epinephrine a good marker of severity of allergic reactions during oral food challenges?</gtr:title><gtr:parentPublicationTitle>The journal of allergy and clinical immunology. In practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2549dbaa3240cc07a8213cd0d29ecc53"><gtr:id>2549dbaa3240cc07a8213cd0d29ecc53</gtr:id><gtr:otherNames>Santos AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>5675e41c22576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BD2A583-2656-4BCC-AB12-18421A5960BF</gtr:id><gtr:title>Road map for the clinical application of the basophil activation test in food allergy.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2549dbaa3240cc07a8213cd0d29ecc53"><gtr:id>2549dbaa3240cc07a8213cd0d29ecc53</gtr:id><gtr:otherNames>Santos AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>5a2fd33ded5a51.15271117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8207E03F-6C5F-4CA8-ABFF-D8DE55105E4E</gtr:id><gtr:title>IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2549dbaa3240cc07a8213cd0d29ecc53"><gtr:id>2549dbaa3240cc07a8213cd0d29ecc53</gtr:id><gtr:otherNames>Santos AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>5675dfa18d5b9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C90E79B-518B-40B1-BC7E-A4D25261F728</gtr:id><gtr:title>Commentary on 'glucocorticoids for the treatment of anaphylaxis'.</gtr:title><gtr:parentPublicationTitle>Evidence-based child health : a Cochrane review journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2549dbaa3240cc07a8213cd0d29ecc53"><gtr:id>2549dbaa3240cc07a8213cd0d29ecc53</gtr:id><gtr:otherNames>Santos AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1557-6272</gtr:issn><gtr:outcomeId>pm_12769_29_23877943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD3464CA-B0E5-4774-870E-D7C4440D5434</gtr:id><gtr:title>Management of anaphylaxis: a systematic review.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0961a81b170af963c103f4234fb8ed5"><gtr:id>b0961a81b170af963c103f4234fb8ed5</gtr:id><gtr:otherNames>Dhami S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>545e50d4256596.76586863</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902018</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>